DigitalHealth.London RADIANT-CERSI Innovator Support Programme

Supporting UK innovators to navigate regulatory pathways for SaMD and AIaMD.

The DigitalHealth.London RADIANT-CERSI Innovator Support Programme is a high-value, fully funded online initiative designed to help UK-based digital health start-ups better understand and navigate the regulatory landscape for Software as a Medical Device (SaMD) and Artificial Intelligence as a Medical Device (AIaMD).

Delivered in partnership with leading experts and organisations across the UK, this programme empowers innovators to bring safe, effective digital health solutions to market faster and with confidence.

Who is it for?

This programme is open to UK-based start-up companies working on SaMD or AIaMD products of any classification (Class I, IIa, IIb, III), with a Technology Readiness Level (TRL) of 4 or above.

What’s involved?

Running from Monday 16 June to Sunday 14 September 2025, the programme features nine live online workshops (up to 2.5 hours each), covering:

• Navigating UK and global regulatory requirements for SaMD and AIaMD

• Developing and evaluating digital health technologies in a regulatory context

• Planning regulatory compliance activities strategically

• Engaging with regulators, experts, and peers across the ecosystem

• Accessing tools, resources, and networks through the broader RADIANT-CERSI collaboration

Our 2025 Cohort

🚀 The programme has launched! Over the coming weeks, 66 UK-based innovators will participate in our workshop series, delivered by Health Innovation Network South London and an expert faculty including:

8foldGovernance, Artificial Intelligence Centre for Value Based Healthcare, Assuric, Blüm Health, Brunel University London, Guy’s and St Thomas’ NHS Foundation Trust, Hardian Health, Imperial College London, and others.

Their solutions span self-management, diagnostics, cardiovascular disease, mental health, and more.

Together, we’re building regulatory confidence and accelerating safer innovation.